comparemela.com

Latest Breaking News On - Medical treatments procedures - Page 3 : comparemela.com

Home buyers are moving because of politics, real-estate agents say: Redfin

One-third of real-estate agents say they have worked with buyers who moved over the last 12 months mainly because of state or local laws or politics,.

United statesSan franciscoNew yorkAndrew vallejoUs supreme courtWest coastThin blue lineArticle normalReal estate agents brokersReal estate services transactionsConstruction real estateReal estatePolitical general newsSociety communityGun controlPersonal finance

Gun, abortion and LGBTQ laws are affecting where home buyers move, Redfin says

One-third of real-estate agents say they have worked with buyers who moved over the last 12 months mainly because of state or local laws or politics,.

United statesSan franciscoNew yorkAndrew vallejoUs supreme courtAustin based andrew vallejoWest coastThin blue lineArticle normalReal estate agents brokersReal estate services transactionsConstruction real estateReal estatePolitical general newsSociety communityGun control

Merck fourth-quarter results top estimates, fueled by cancer drugs and vaccines

Merck on Thursday reported fourth-quarter earnings and sales that beat analyst expectations, powered by strong growth in cancer and vaccine products.

Daiichi sankyoRobert davisMerck coHarpoon therapeutics incHarpoon therapeuticsInflation reduction actArticle normalCancer drugsHealthcare life sciencesSpecialized drugs medicationsFinancial performanceSales figuresEarnings surprisesNew products servicesCorporate industrial newsProducts services

GSK lifts long-term outlook following launch of blockbuster vaccine in 2023

The FTSE-100 drugmaker predicted new drug and vaccine launches will see its annual sales hit £38 billion by 2031

City ofUnited kingdomEmma walmsleyDrug administrationArticle normalScientific research servicesHealth careBusiness consumer servicesSpecialized drugs medicationsMedical research servicesDrug discovery developmentHealthcare support servicesDiagnostic medical research servicesFinancial performanceSales figuresNew products services

GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales -- 2nd Update

By Joe Hoppe GSK expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the.

United kingdomJoe hoppeEmma walmsleyVisible alphaSpecialty medicinesExecutive emma walmsleyArticle normalHealthcare life sciencesSpecialized drugs medicationsFinancial performanceSales figuresCorporate industrial newsPolitical general newsMedical treatments proceduresContent typesFactiva filters

vimarsana © 2020. All Rights Reserved.